Citation Impact
Citing Papers
Reactivation of Ocular Dominance Plasticity in the Adult Visual Cortex
2002 StandoutScience
New clinical trials for nonmotor manifestations of Parkinson's disease
2015
Sublingual apomorphine (APL‐130277) for the acute conversion of OFF to ON in Parkinson's disease
2016
Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability
2017
Developing dopaminergic cell therapy for Parkinson's disease—give up or move forward?
2013
Cell-based therapies for Parkinson disease—past insights and future potential
2015
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP)
1992
Parkinson disease
2017 Standout
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
2019
Signal transduction via platelet-derived growth factor receptors
1998
Restless Legs Syndrome
2008
Myelination of the canine central nervous system by glial cell transplantation: A model for repair of human myelin disease
1997
Parkinson's disease
2021 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
1999
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
2010
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
2014
Parkinson's disease: The quintessential neuropsychiatric disorder
2011
Spinal-cord injury
2002 Standout
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
Down‐regulation of E‐cadherin expression in madin darby canine kidney (MDCK) cells inside tumors of nude mice
1991
Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System
1999 Standout
Progenitor Cell Biology
1999
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?
2016
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
2003
The generation of diversity and pattern in animal development
1992 StandoutNobel
Defects in enteric innervation and kidney development in mice lacking GDNF
1996 StandoutNature
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
2012
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
2004
The pathophysiological basis of sensory disturbances in Parkinson's disease
2009
CEACAM1: contact-dependent control of immunity
2006
Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
2002
Hepatocyte Polarity
2012
Synaptic transmission: A bidirectional and self-modifiable form of cell-cell communication
1993 StandoutNobel
Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's Disease
1995
The glial scar and central nervous system repair
1999
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
2014
Pains in Parkinson disease—many syndromes under one umbrella
2012
Parkinson's disease
2009 Standout
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
1995
Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits
2013
Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's Disease
1992
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
2015
A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells
2007 Standout
Late-stage Parkinson disease
2012
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
2018
Sensory aspects of movement disorders
2013
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain
2015
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
1995 Nature
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Parkinson's disease
2015 Standout
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
2003
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
2015
Parkinson's Disease: Past, Present, and Future
1993
Depression and Quality of Life in Older Persons: A Review
2015 Standout
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) Mice
2012
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
2013
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease
2011
Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months after Transplantation for Parkinson's Disease
1992
Chondroitinase ABC promotes functional recovery after spinal cord injury
2002 StandoutNature
Long-Term Survival of Human Central Nervous System Progenitor Cells Transplanted into a Rat Model of Parkinson's Disease
1997
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Mechanisms of action of deep brain stimulation (DBS)
2007
High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain
2001 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Gender and non motor fluctuations in Parkinson's disease: A prospective study
2016
What we can do and what we cannot do with fMRI
2008 StandoutNature
Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease
2002
GDNF signalling through the Ret receptor tyrosine kinase
1996 StandoutNature
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases
2019
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
1999
Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain
1999 Standout
Non-motor features of Parkinson disease
2017 Standout
Multiple Sclerosis
2000 Standout
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
2005
Gastrointestinal dysfunction in Parkinson's disease
2015
Post-Traumatic Growth After a Myocardial Infarction: A Matter of Personality, Psychological Health, or Cognitive Coping?
2008 Standout
Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines
1998
Intercellular communication in the brain: Wiring versus volume transmission
1995
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
1999
Mechanisms of Bone Metastasis
2004 Standout
Clinical management of pain and fatigue in Parkinson's disease
2011
Imaging biomarkers in Parkinson's disease
2011
The clinical potential of stem cells
2004
Animal models of the non-motor features of Parkinson's disease
2012
Platelet-Derived Growth Factor Receptor Association with Na+/H+ Exchanger Regulatory Factor Potentiates Receptor Activity
2000 StandoutNobel
Renal agenesis and the absence of enteric neurons in mice lacking GDNF
1996 StandoutNature
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease
1995
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
PDGF and its receptors following facial nerve axotomy in rats: expression in neurons and surrounding glia
1995
Parkinson's Disease
2003 Standout
The WHO-5 Well-Being Index: A Systematic Review of the Literature
2015 Standout
Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease
2019
Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease
1996
Reliability and validity of the S panish version of the W orld H ealth O rganization‐F ive W ell‐B eing I ndex in elderly
2012
The Validity of the WHO-5 as an Early Screening for Apathy in an Elderly Population
2012
Hypoxia induces an autocrine‐paracrine survival pathway via platelet‐derived growth factor (PDGF)‐B/PDGF‐β receptor/phosphatidylinositol 3‐kinase/Akt signaling in RN46A neuronal cells
2003
2020
Editorial Expression of Concern for multiple articles
2008 StandoutNobel
Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity
2018
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Sleep matters in P arkinson's disease: use of a priority list to assess the presence of sleep disturbances
2012
Pharmacological Treatment of Parkinson Disease
2014
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers
2004 StandoutScience
Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells.
1991
Novel formulations and modes of delivery of levodopa
2014
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
2015
Spatial and temporal distribution of the adherens-junction-associated adhesion molecule A-CAM during avian embryogenesis
1988
Developmental Expression of Platelet-Derived Growth Factor α-Receptor in Neurons and Glial Cells of the Mouse CNS
1997
Cell Therapy for Parkinson's Disease: What Next?
2013
Hydrogel bioelectronics
2018 Standout
Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
2018
Nonmotor features of Parkinson's disease subtypes
2016
Cell Adhesion Molecules in the Regulation of Animal Form and Tissue Pattern
1986 Nobel
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
2013
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
1991 StandoutScience
Loss of competence in amphibian induction can take place in single nondividing cells.
1989 StandoutNobel
Physiotherapy in Parkinson’s Disease: A Meta-Analysis of Present Treatment Modalities
2020
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
The spectrum of nonmotor symptoms in early Parkinson disease
2013
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Soluble 80‐kd fragment of cell‐CAM 120/80 disrupts cell‐cell adhesion
1987
Beside the Geriatric Depression Scale: the WHO‐Five Well‐being Index as a valid screening tool for depression in nursing homes
2013
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a P arkinson disease patient
2016
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
2000 Standout
Should treatment of Parkinson's disease be started with a dopamine agonist?
1998
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
2001
2016
Nonmotor Symptoms in Nursing Home Residents with Parkinson's Disease: Prevalence and Effect on Quality of Life
2013
Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease
2001
Stem Cells in the Central Nervous System
1997 Science
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Modulation of an NCAM-Related Adhesion Molecule with Long-Term Synaptic Plasticity in Aplysia
1992 StandoutScienceNobel
Works of Per Odin being referenced
Chronic Subcutaneous Infusion Therapy with Apomorphine in Advanced Parkinson's Disease Compared to Conventional Therapy: A Real Life Study of Non Motor Effect
2011
Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results
2014
The challenge of non-motor symptoms in Parkinson’s disease
2010
Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom
2010
The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system
2015
Clinical risk–benefit assessment of dopamine agonists
2008
Expression of platelet-derived growth factor after intrastriatal ibotenic acid injury
1998
Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
1997
Enhanced synthesis of platelet-derived growth factor following injury induced by 6-hydroxydopamine in rat brain
1996
Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants
1992
Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
2010
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture
1993
Parkinson’s disease: The non-motor issues
2011
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire
2010
Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up
1998
Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32-containing neurones
1994
Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life
2009
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program
2015
Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture
1996
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
2011
Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease
2008
Immunohistochemical localization of cellCAM 105 in rat tissues: appearance in epithelia, platelets, and granulocytes.
1988
The cell-surface expression of the cell adhesion molecule cellCAM 105 in rat fetal tissues and regenerating liver
1988
Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery
2013
Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care
2013
Intermuscular coherence in Parkinson's disease: relationship to bradykinesia
2001
Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's disease
1994
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET
2001
Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon
1996
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
2016
Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
2013
A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
2013
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial
2020
Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome
2004
Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease
2010
Wearing‐off scales in Parkinson's disease: Critique and recommendations
2011
Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease
2012
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
2013
Intermuscular coherence in Parkinson's disease: effects of subthalamic nucleus stimulation
2001
Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro
1995
Comparison of two cell-adhesion molecules, uvomorulin and cell-CAM 105
1985
Trophectoderm surface expression of the cell adhesion molecule cell-CAM 105 on rat blastocysts
1987
P2.149 Efflcacy of apomorphine infusion on mood and depression aspects of non-motor symptoms in advanced Parkinson's disease
2009
Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease
2011
Quantitative determination of the organ distribution of the cell adhesion molecule cell-CAM 105 by radioimmunoassay
1987
P1.229 Improvement of motor and non-motor symptoms after switching from oral therapy to continuous duodenal levodopa infusion in advanced Parkinson's disease
2009
Expression of Platelet-Derived Growth Factor in and around Intrastriatal Embryonic Mesencephalic Grafts
1993
Chemical characterization of cell-CAM 105, a cell-adhesion molecule isolated from rat liver membranes
1986
A Consensus Set of Outcomes for Parkinson’s Disease from the International Consortium for Health Outcomes Measurement
2017
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID ‐19 Experience
2020
Dynamic expression of the cell adhesion molecule cell-CAM 105 in fetal and regenerating rat liver
1986
Nonmotor fluctuations in Parkinson disease
2013
Restless legs syndrome and PD
2003
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation
2015